These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8463994)

  • 1. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms.
    Bancroft J; Rennie D
    J Psychosom Res; 1993; 37(2):195-202. PubMed ID: 8463994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.
    Graham CA; Sherwin BB
    J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms.
    Graham CA; Sherwin BB
    Psychoneuroendocrinology; 1993; 18(4):273-81. PubMed ID: 8316616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between premenstrual symptoms and oral contraceptive use: a controlled study.
    Walker A; Bancroft J
    Psychosom Med; 1990; 52(1):86-96. PubMed ID: 2305025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood, sexuality, oral contraceptives and the menstrual cycle.
    Warner P; Bancroft J
    J Psychosom Res; 1988; 32(4-5):417-27. PubMed ID: 3236269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between retrospective premenstrual symptom reporting and present oral contraceptive use.
    Graham CA; Sherwin BB
    J Psychosom Res; 1987; 31(1):45-53. PubMed ID: 3820145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood changes during the menstrual cycle and their relation to the use of oral contraceptive.
    Almagor M; Ben-Porath YS
    J Psychosom Res; 1991; 35(6):721-8. PubMed ID: 1791586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors related to self-reporting of the pre-menstrual syndrome.
    Warner P; Bancroft J
    Br J Psychiatry; 1990 Aug; 157():249-60. PubMed ID: 2224376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food craving, mood and the menstrual cycle.
    Bancroft J; Cook A; Williamson L
    Psychol Med; 1988 Nov; 18(4):855-60. PubMed ID: 3270830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraception and cyclic changes in premenstrual and menstrual experiences.
    Abraham S; Luscombe G; Soo I
    J Psychosom Obstet Gynaecol; 2003 Sep; 24(3):185-93. PubMed ID: 14584305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospectively reported symptom change across the menstrual cycle in users and non-users of oral contraceptives.
    Ross C; Coleman G; Stojanovska C
    J Psychosom Obstet Gynaecol; 2003 Mar; 24(1):15-29. PubMed ID: 12685336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eating disorder pathology and menstrual cycle fluctuations in eating variables in oral contraceptive users and non-users.
    McVay MA; Copeland AL; Geiselman PJ
    Eat Behav; 2011 Jan; 12(1):49-55. PubMed ID: 21184973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception.
    Borges LE; Andrade RP; Aldrighi JM; Guazelli C; Yazlle ME; Isaia CF; Petracco A; Peixoto FC; Camargos AF
    Contraception; 2006 Dec; 74(6):446-50. PubMed ID: 17157100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations.
    Bäckström T; Hansson-Malmström Y; Lindhe BA; Cavalli-Björkman B; Nordenström S
    Contraception; 1992 Sep; 46(3):253-68. PubMed ID: 1451521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives positively affect mood in healthy PMS-free women: A longitudinal study.
    Hamstra DA; de Kloet ER; de Rover M; Van der Does W
    J Psychosom Res; 2017 Dec; 103():119-126. PubMed ID: 29167038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vulnerability to perimenstrual mood change: the relevance of a past history of depressive disorder.
    Bancroft J; Rennie D; Warner P
    Psychosom Med; 1994; 56(3):225-31. PubMed ID: 8084968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Cyclic Hormonal Contraception on Expression of Premenstrual Syndrome.
    Yonkers KA; Cameron B; Gueorguieva R; Altemus M; Kornstein SG
    J Womens Health (Larchmt); 2017 Apr; 26(4):321-328. PubMed ID: 27854559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms.
    Brown C; Ling F; Wan J
    J Reprod Med; 2002 Jan; 47(1):14-22. PubMed ID: 11838304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postural control in women with premenstrual symptoms during oral contraceptive treatment.
    Ekenros L; Hirschberg AL; Bäckström T; Fridén C
    Acta Obstet Gynecol Scand; 2011 Jan; 90(1):97-102. PubMed ID: 21275922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.